Episode 473: Episode 22-24 Biotech Beyond Covid

On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma about its approach to Acute Myeloid Leukemia, also known as AML. Then Dr. Nik Sopko, the Chief Scientific Officer of PolarityTE talks about their design for wound healing. Their first treatment candidate is diabetic foot ulcers. And Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.